These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6112242

  • 1. A radioreceptor assay for neuroleptic drugs in plasma.
    Lader SR.
    J Immunoassay; 1980; 1(1):57-75. PubMed ID: 6112242
    [Abstract] [Full Text] [Related]

  • 2. Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics.
    Harris PQ, Brown SJ, Friedman MJ, Bacopoulos NG.
    Biol Psychiatry; 1984 Jun; 19(6):849-60. PubMed ID: 6146355
    [Abstract] [Full Text] [Related]

  • 3. Thioridazine and the neuroleptic radioreceptor assay.
    Mailman RB, Pierce JP, Crofton KM, Petitto J, DeHaven DL, Kilts CD, Lewis MH.
    Biol Psychiatry; 1984 Jun; 19(6):833-47. PubMed ID: 6743721
    [Abstract] [Full Text] [Related]

  • 4. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
    Krska J, Sampath G, Shah A, Soni SD.
    Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755
    [Abstract] [Full Text] [Related]

  • 5. Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity.
    Rao ML.
    Psychopharmacology (Berl); 1986 Feb; 90(4):548-53. PubMed ID: 2880364
    [Abstract] [Full Text] [Related]

  • 6. On the clinical relevance and methods of quantification of plasma concentrations of neuroleptics.
    Ko GN, Korpi ER, Linnoila M.
    J Clin Psychopharmacol; 1985 Oct; 5(5):253-62. PubMed ID: 2864357
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma level monitoring of antipsychotic drugs. Clinical utility.
    Dahl SG.
    Clin Pharmacokinet; 1986 Oct; 11(1):36-61. PubMed ID: 2868820
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
    Young AS, Faraone SV, Brown WA.
    J Clin Psychopharmacol; 1989 Oct; 9(5):361-3. PubMed ID: 2571620
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population.
    Dunlop SR, Shea PA, Hendrie HC.
    Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231
    [Abstract] [Full Text] [Related]

  • 19. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
    Rao ML, Brown WA.
    Psychopharmacology (Berl); 1987 Aug; 93(2):237-42. PubMed ID: 2892222
    [Abstract] [Full Text] [Related]

  • 20. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
    Marshall AM, Mishra RK.
    Adv Biochem Psychopharmacol; 1980 Aug; 24():153-7. PubMed ID: 6105772
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.